Indegene Strengthens European Presence with New Centre in London
Indegene Strengthens European Presence with New Centre in London

Indegene Strengthens European Presence with New Centre in London

Indegene Limited, established in 1998, is a digital-first healthcare and technology company that supports biopharmaceutical, emerging biotech, and medical device companies in product development and market entry.

DSIJ Intelligence-1 Article rating: 5.0

Indegene's workforce in Europe is being strengthened with expertise in consulting, creative, data and analytics, engineering, and customer experience.  

These 5 Companies Have Doubled Their Capex in Just 3 Years – Is Your Portfolio Missing Out?
These 5 Companies Have Doubled Their Capex in Just 3 Years – Is Your Portfolio Missing Out?

These 5 Companies Have Doubled Their Capex in Just 3 Years – Is Your Portfolio Missing Out?

Discover the 5 companies that have doubled their capital investments in the last 3 years—driven by government spending and future growth ambitions!

DSIJ Intelligence Article rating: 5.0

Discover the 5 companies that have doubled their capital investments in the last 3 years—driven by rising government spending and future growth ambitions!

EV-Bike Manufacturer Expands Global Footprint with Entry into Nepal
EV-Bike Manufacturer Expands Global Footprint with Entry into Nepal

EV-Bike Manufacturer Expands Global Footprint with Entry into Nepal

The stock fell 33 per cent in the last 1 year and in 3 years the stock is down by 15 per cent, with a price-earnings (PE) ratio of 15.

DSIJ Intelligence-1 Article rating: 5.0

The stock fell 33 per cent in the last 1 year and in 3 years the stock is down by 15 per cent, with a price-earnings (PE) ratio of 15.

Airline Stock Under Rs 60 In Focus As It Announces Successful Fund Infusion of Rs 294.09 Crore by Promoter Group, Raising Stake to 33.47 Per Cent
Airline Stock Under Rs 60 In Focus As It Announces Successful Fund Infusion of Rs 294.09 Crore by Promoter Group, Raising Stake to 33.47 Per Cent

Airline Stock Under Rs 60 In Focus As It Announces Successful Fund Infusion of Rs 294.09 Crore by Promoter Group, Raising Stake to 33.47 Per Cent

In its annual results, the company reported net sales of Rs 7,085 crore, an operating loss of Rs 644 and a net loss of Rs 424 crore in FY24.

DSIJ Intelligence-1 Article rating: 4.0

This infusion finalizes the promised Rs 500 crore equity investment by Ajay Singh, bolstering SpiceJet's financial stability.

RSS
First8687888991939495Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR